For over eight years, Slender-Tech® has been dedicated to advancing low-level laser therapy (LLLT) through rigorous clinical research. In 2020, this commitment led to a pioneering breakthrough when Slender-Tech became the first to secure regulatory clearance for a non-invasive fat reduction soft laser, launching the innovative OLI-Fat Reduction Laser category.
This new category has elevated body contouring standards, providing a safe and effective alternative to traditional fat loss methods and establishing Slender-Tech as the leader in low-level laser technology for fat reduction.
Today, Slender-Tech’s solutions are celebrated for their precision, safety, and effectiveness, setting a new industry benchmark. Clinical trials of Slender’s green laser have shown it to be both side-effect-free and 23% more energy-efficient than red lasers, making Slender-Tech the safest, most effective choice in fat reduction technology.
Discover the double-blind, randomized, placebo-controlled studies that validate the effectiveness of Slender-Tech’s soft laser technology for individuals with a BMI between 20 and 40.
Slender-Tech® low-level soft lasers stimulate cytochrome C oxidase, enhancing mitochondrial activity and leading to increased production of ATP, NADH, RNA, and overall cellular respiration. This process also boosts nitric oxide synthase activity, elevates nitric oxide levels, and increases reactive oxygen species, which are essential for cell signaling, cell cycle progression, enzyme activation, and the synthesis of proteins and nucleic acids.
Importantly, the lipid release triggered by LLLT does not raise plasma lipid, triglyceride, or cholesterol levels.